Sara Matos

Fábio Gomes

Micaela Peixoto

Joaquim Tinoco

Fernanda Alves dos Reis

Cláudia Mendes Videira

27 February 2026

Champalimaud Foundation’s brand reputation over time: results, context, and reflection

Brand rankings and reputation studies are published every year, nationally and internationally, often attracting attention for their league tables and headline positions. While such studies are inevitably shaped by methodological choices, sampling criteria, and contextual factors, they can nonetheless offer a useful lens for understanding how organisations are perceived within a shared ecosystem.

23 December 2025

Champalimaud Foundation’s Gynaecology Unit Triples Annual Volume of Robotic Surgeries

Between February 2017 and December 2020, the team performed approximately 200 robotic procedures. Over the subsequent five years, from December 2020 to December 2025, this number more than doubled, reaching 500 procedures, an achievement that reflects the consolidation of a nationally recognised reference programme with extensive experience in robotic gynaecological surgery.

18 December 2025

Inês Pires da Silva Receives Two Prestigious Australian Awards for Groundbreaking Work in Melanoma Research

As a winner of the Outstanding Mid-Career Researcher Award, Inês Pires da Silva was recognised for her exceptional progress and global impact in translational cancer research. She has led international studies that have shaped current clinical practice and advanced scientific understanding of resistance mechanisms in immunotherapy.

17 December 2025

Why Transcranial Magnetic Brain Stimulation Stands Out as a Promising Therapeutic Solution for Bipolar Depression

Since the 1990s, non-invasive brain stimulation has grown from an experimental idea into an established tool for treating depression as well as advancing neuroscience research. Among these technologies, repetitive transcranial magnetic stimulation (rTMS) is clinically validated and used to treat major depressive disorder, also known as unipolar depression.

Subscribe to Services
Loading
Please wait...